Fifth Third Bancorp
ROIV icon

Fifth Third Bancorp’s Roivant Sciences ROIV Stock Holding History

Fifth Third Bancorp’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Sell
4,329
-357
-8% -$10.6K ﹤0.01% 2750
2026
Q1 		$130K Buy
4,686
+376
+9% +$9.66K ﹤0.01% 2777
2025
Q4 		$93.5K Buy
4,310
+588
+16% +$11.6K ﹤0.01% 1221
2025
Q3 		$56.3K Buy
3,722
+433
+13% +$5.36K ﹤0.01% 1447
2025
Q2 		$37.1K Sell
3,289
-1,829
-36% -$19.8K ﹤0.01% 1536
2025
Q1 		$51.6K Buy
5,118
+1,905
+59% +$20.6K ﹤0.01% 1392
2024
Q4 		$38K Buy
3,213
+567
+21% +$6.7K ﹤0.01% 1492
2024
Q3 		$30.5K Buy
2,646
+585
+28% +$6.66K ﹤0.01% 1624
2024
Q2 		$21.8K Buy
2,061
+1,987
+2,685% +$21.8K ﹤0.01% 1696
2024
Q1 		$780 Hold
74
– – ﹤0.01% 2289
2023
Q4 		$831 Buy
+74
New +$721 ﹤0.01% 2421

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fifth Third Bancorp's ROIV Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Roivant Sciences (ROIV) stake by 7.6% in Q2 2026, selling an estimated $10.6K and leaving 4,329 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Fifth Third Bancorp first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Fifth Third Bancorp held 4,329 shares of Roivant Sciences worth $153K as of Q2 2026.
  • Fifth Third Bancorp sold 357 Roivant Sciences shares in Q2 2026, an estimated $10.6K.
  • Roivant Sciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2750 holding.
  • Fifth Third Bancorp first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.